GenAI Startups Defy ‘Startup Winter,’ Raise Record $10 Billion in 2023

• ByStartupStory     |    December 12, 2023

In contrast to an overall decline in startup funding in 2023, Generative AI (GenAI) startups have showcased resilience, securing a record $10 billion in funding, marking a substantial 110% increase compared to 2021. This remarkable achievement for GenAI startups stands out as total venture capital funding experienced a notable 65% drop, reaching $224 billion, leading to what has been termed as a ‘startup winter,’ attributed to rising interest rates, recessionary risks, and a challenging macro environment.

The ability of GenAI startups to thrive in this challenging landscape underscores the transformative potential of this technology across various sectors and industries. The report by GlobalData highlights that since 2018, US-based GenAI startups have dominated funding, accounting for 75% of the total amount raised, which equates to $16 billion. Additionally, contributions from Israel, Germany, France, the UK, and China make up the remaining 15%. Notably, early-stage startups constituted 40% of all deal volumes, indicating a significant focus on the initial funding of GenAI startups.

The report projects a continued attraction of investment in GenAI startups throughout 2024 and beyond. Factors contributing to this positive outlook include an accelerating trend in startup funding, an impressive 85% Compound Annual Growth Rate (CAGR) in patenting activity over the last five years, and an aggressive recruitment drive for GenAI talent across various sectors.

Investor response to GenAI startups has been favorable, with companies specializing in GenAI capabilities witnessing higher valuations. A noteworthy example is Google, whose share price experienced a 5% increase following the announcement of its latest artificial intelligence model, Gemini.

Among the GenAI startups that secured funding in 2023, Sarvam AI from India notably raised $41 million to develop GenAI solutions catering to the diverse languages in India. Another standout is Cradle from the Netherlands, which utilizes GenAI for protein design and engineering, securing $24 million in funding.

In conclusion, GenAI emerges as a technology innovation that has made a significant impact across industries in a relatively short period. With its transformative potential and positive industry response, GenAI is well-positioned to continue attracting investments throughout 2024 and beyond.

Follow Startup Story